AbbVie (ABBV)

$106.70 1.05 (0.99%)

19:56 EST ABBV Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 169.32B

PE Ratio 26.81

EPS 3.98

Volume (Avg. Vol.) 7.28M

Day's Range 104.07 - 106.99

52-Week Range 62.55 - 113.41

Dividend & Yield 5.20 (4.87%)

ABBV Stock Predictions, Articles, and AbbVie News

From InvestorPlace
From the Web

7 Great Dividend Stocks Outside the Energy Sector

By Alex Sirois Mar 3, 2021

Dividend stocks come in many flavors although investors may associate them primarily with the energy sector. These seven stocks cross industries.

7 Safe Stocks You Can Hold Onto Forever

By Chris Lau, InvestorPlace Contributor Mar 1, 2021

Euphoric markets are widening the gap between value and growth investments. Let's take a look at safe stocks to buy and hold forever.

9 Safe Stocks for Your 401k

By Josh Enomoto, InvestorPlace Contributor Feb 16, 2021

While everybody is chasing the moon and the stars, it might be prudent for you to consider these safe stocks for your 401K.

4 Top Stock Trades for Thursday: AMZN, SPOT, BMY, ABBV

By Bret Kenwell, InvestorPlace Contributor Feb 3, 2021

Amazon, Spotify, Bristol-Myers Squibb and AbbVie were our top stock trades for Thursday. Let's look at the charts of these earnings movers.

7 Pharmaceutical Stocks With Compelling Pipelines

By Chris Lau, InvestorPlace Contributor Feb 2, 2021

Covid-19 vaccines are getting all the glory after multi-bagger returns last year but these seven pharmaceutical stocks have a strong future ahead.

7 Dividend Aristocrats That Will Outlive Us All

By Tezcan Gecgil, InvestorPlace Contributor Jan 22, 2021

These seven Dividend Aristocrats are among the royalty of passive-income generator companies

7 Pharmaceutical Stocks With Exciting Plans for 2021

By Bret Kenwell, InvestorPlace Contributor Jan 13, 2021

Pharmaceutical stocks have many benefits, particularly when their products are in demand. And in 2021, that seems likely to be the case.

7 Hot Stocks That Will Keep You Energized With 3%-Plus Yields

By Louis Navellier and the InvestorPlace Research Staff, Editor, Growth Investor Jan 11, 2021

These hot stocks combine healthy dividends with lasting brand names, making them some of the smartest picks on the market.

The Top 7 Pharmaceutical Stocks for the Next 10 Years

By Alex Sirois Jan 11, 2021

Pharmaceutical stocks can be a great investment in a unique niche of the market. The stocks on this list will be strong for a decade plus.

7 Safe Stocks to Buy to Start Off the Year

By Faisal Humayun Jan 7, 2021

These safe stocks to buy have a low beta, attractive valuation and healthy dividends. Get in early this year to strengthen your portfolio.

7 Cheap Stocks to Buy in January For a Quick Buck

By Alex Sirois Jan 4, 2021

2020 has taken the market capitalizations of many strong companies to lows. That means there are some great options for cheap stocks to buy in January.

5 Dividend Stocks Likely to Up Their Yield Soon

By Stavros Georgiadis, CFA, InvestorPlace Contributor Dec 23, 2020

Dividend stocks are a special category of financial assets, providing a lot of benefits for investing that make them attractive for the majority of investors.....

7 Medical Marijuana Stocks for a Healthcare Revolution

By Tom Taulli, InvestorPlace Writer & IPO Playbook Editor Dec 7, 2020

Medicinal cannabis is no longer speculative. There are truly impactful treatments out there, as well as investment-worthy marijuana stocks.

7 Cheap Stocks to Buy Before the Market Realizes their Worth

By Bret Kenwell, InvestorPlace Contributor Dec 7, 2020

Almost everyone likes cheap stocks, because as investors, we don't like to overpay. Some are value traps, while others are treasure chests.

3 Dividend Stocks for Big Total Returns in 2021

By Muslim Farooque Dec 3, 2020

These dividend stocks continue to outperform thier competition in yielding higher and consistent returns despite the impact of the pandemic

4 Pharmaceutical Stocks That Aren’t Worth Their Outsized 2020 Gains

By Joel Baglole Dec 1, 2020

Now that companies such as Pfizer, Moderna and AstraZeneca have emerged with viable vaccines against Covid-19, the hype around many pharmaceutical stocks is fading. Here are four stocks investors should be weary of in the weeks ahead.